The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Ottawa, Canada
11-50 Employees
2016
We are among the first to introduce certain innovative technologies in Canada. We are presently the only pain clinic in the greater Ottawa area to offer treatments aimed at regenerating and rejuvenating cell tissues. At Inovo Medical, we are aware that the pain is very real. We are among the first to introduce regenerative medicine technology in Canada and one of the only clinics in the greater Ottawa area to offer regenerative medicine for pain relief, sexual wellness and cosmetic treatments. A recent addition to Ottawa’s medical community, Inovo Medical stands out for its innovative medical practices, including an approach that is revolutionizing medicine as you know it. Our medical clinic provides a number of services: chronic pain medicine, sports and joint medicine, regenerative medicine, and conventional and regenerative aesthetic medicine. Inovo Medical also provides non-forensic medical expertise to public and private insurers as well as to employers to assess predefined medical diagnoses and propose novel curative treatments. This is why our experts treat the various sources of pain and identify how they interact on body mechanics as a whole.
+
Featured
Regenerative Medicine
... Inovo Medical is a canadian regenerative medicine clinic located in Ottawa, ON. We offer regenerative treatments for musculoskeletal conditions. Our regenerative solutions include stem cell therapy, PRP therapy, nerve hydrodissection and dextrose prolotherapy. ...
Roswell, United States
51-100 Employees
2015
StimLabs has continued to grow over the years across multiple campuses. We are continuously focused on developing a diverse spectrum of technologies that can capture the intrinsic capabilities of the human body to accelerate the healing cascade - these technologies are the future of regenerative medicine. In 2002, after becoming practiced in all facets of the industry, John founded a successful consultancy business to help other companies problem-solve, scale, and grow. After years of bringing innovative and life-changing products successfully to market, John co-conceptualized the next iteration of the placental allograft: an allograft composed of the amnion and chorion layers of the placental membrane. John’s inventions and product development methods are still in use today. Within the first year, 16,000 square feet of office and processing space was built, and the flagship product, Revita®, was launched. Revita, and the patented technology behind its creation, were quickly recognized as the next generation of placental allografts. Over the next few years, a suite of revolutionary placental-derived products and intellectual property was developed and Beyond Birth®, StimLabs’ tissue donation program, was founded.
+
Featured
Advancing the State of Regenerative Medicine
... As a trusted source in regenerative medicine, we use our unique expertise to offer the highest-quality solutions and first-rate services that support physicians and patients alike. ...
Cambridge, United States
1-10 Employees
2019
At Satellite Bio, we’re on a journey to tackle severe, life threatening conditions without a cure or effective treatment. We believe that we are on the precipice of something truly great: a new way to restore hope to patients suffering from the world’s most elusive diseases. We are deeply committed to leading and realizing the potential of this exciting new frontier in regenerative medicine. At Satellite Bio, we’ve found a better way to take on diseases without a cure or effective treatment. With Satellite Adaptive Tissues—known as Satellites—we are unlocking a new approach to the assembly of healthy cells for use as a therapy that will change the course of some of the most elusive diseases today. Our Satellite Adaptive Tissue (SAT) Platform will drive a pipeline of sophisticated cell-based therapeutic solutions designed to tackle a broad range of diseases and conditions. We are a passionate, interdisciplinary team that collaborates deeply and thinks differently. Guided by our core values of authenticity, tenacity, courage, and integrity, we are standing on the shoulders of giants, and working together to make the greatest possible advances every day.
+
Featured
Pioneering the next frontier of regenerative medicine.
... It’s an audacious journey, and it’s led us to an entirely new category of regenerative medicine: Tissue Therapeutics. ...
Nashville-Davidson, United States
11-50 Employees
2013
Our mission is to deliver quality care based on compassion and clinical excellence to patients who want to optimize their health and achieve an individualized age management solution.
+
Featured
Regenerative Medicine
... Regenerative Medicine - Nashville, TN: Ageless Regenerative Medical: Regenerative Medicine ...
United States
11-50 Employees
Novo Wellness is a regenerative medicine and pain management clinic serving patients from locations in Aiken and Hilton Head Island, South Carolina. Patients at Novo Wellness have access to state-of-the-art treatment technologies that aim to minimize pain, optimize mobility, and improve life quality by reducing the need for pharmaceuticals, surgery, and other more high-maintenance treatments. For back pain, neck pain, arthritis, and musculoskeletal injuries, Novo Wellness also offers spinal cord stimulation, radiofrequency ablation, and minimally invasive surgery like kyphoplasty. Novo Wellness provides top-of-the-line cosmetic treatments like Morpheus8 radiofrequency microneedling and CoolSculpting® for body contouring. They also offer Botox® for wrinkles and several non-cosmetic purposes, like TMJ pain management and chronic migraines. For relief at home, the practice offers quality locally owned CBD products, doTERRA® essential oils, and hemp wellness products from ProVital Solutions. At Novo Wellness, we strive to provide state of the art treatment for all pain conditions in a comfortable and compassionate setting.
+
Featured
Regenerative Medicine
... Regenerative Medicine - Aiken, SC & Hilton Head Island, SC: Novo Wellness: Regenerative Medicine Pain ...
Austin, United States
11-50 Employees
2019
Amniotic Membrane Wraps Our amniotic membrane wrap is a unique dehydrated human amnion membrane (dHAM) allograft composed primarily of a connective tissue matrix. Amnio for Respiratory Designed to deliver a liquid allograft as a topical therapy for the respiratory system to treat respiratory ailments and systemic inflammation.
+
Featured
Regenerative Medicine Products
... Regenerative Medicine ...
United States
51-100 Employees
1999
GBV was established with a singular mission: to democratize state-of-the-art aesthetic and regenerative treatments, making them available to all. With this central objective, we've pioneered inventive turnkey solutions that enable healthcare providers across the nation to effortlessly incorporate regenerative medicine and aesthetic solutions into their practices. At GBV Medical Solutions, our commitment is to provide transformative products, therapies, and educational resources to physicians, all while upholding the utmost ethical standards in the fields of regenerative medicine and aesthetics. High-quality supplements and luxurious aesthetic beauty products, enabling healthcare practitioners and beauty professionals to enhance wellness and rejuvenate their clients.
+
Featured
GBV Regenerative Medicine Solutions
... GBV is a national sales organization that sells regenerative medicine ...
+
Featured
Pacific Stem Cells
... Regenerative Medicine ...
Raleigh, United States
11-50 Employees
2017
+
Featured
Regenerative Medicine – Living Well Balanced
... Regenerative Medicine – Living Well ...
San Carlos, United States
Regencor, Inc.733 Industrial RoadSan Carlos, CA USA 94070. Regencor's team envisions a future where myocardial infarctions no longer impose incurable & life threatening tissue damage or progression to heart failure. Regencor Announces Sean Edwards as new President & CEO. Subcutaneous Sustained Delivery via Pump:A true game-changer in heart disease therapy. Our recombinant protein, delivered subcutaneously, reverses the formation of scar tissue. Scar tissue is the most serious complication after a myocardial infarction as it weakens the heart and leads to progressive heart failure. NIH Grants to Founders leading to discovery of non-glycosylated FSTL1 as a proprietary therapeutic.
+
Featured
Advancing Regenerative Medicine - Regencor
... A cutting edge therapeutic for modern regenerative medicine. Our recombinant protein reverses the most common complication after a myocardial infarction: scar tissue formation that weakens the heart and leads to progressive heart failure. ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Regenerative Medicine
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 277 |
| Amount of suitable service providers | 267 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1999 |
| Youngest suiting company | 2019 |
Regenerative Medicine is an interdisciplinary field that seeks to repair, replace, regenerate, or enhance the function of diseased, damaged, or aged tissues, organs, and cells. This domain leverages a combination of strategies encompassing the use of biologically active molecules, gene therapy, stem cell transplantation, tissue engineering, and the development of artificial organs or biomaterials. It aims to restore normal function by harnessing the body's innate healing processes or by creating living, functional tissues to replace or repair tissue or organ function lost due to age, disease, damage, or congenital defects. This innovative approach stands in contrast to traditional treatments that may only manage symptoms. The impact of Regenerative Medicine extends across various medical fields, offering potential cures and improving the quality of life for patients suffering from a wide range of conditions, including but not limited to, cardiovascular diseases, diabetes, osteoarthritis, and spinal cord injuries. By focusing on the underlying causes of disease by repairing or replacing damaged cells and tissues, Regenerative Medicine holds the promise of transforming the current healthcare paradigm from one that primarily manages symptoms to one that effectively cures and reverses the progression of serious diseases, thereby significantly reducing healthcare costs and improving patient outcomes.
1. Enhanced Healing and Functionality:
Regenerative medicine offers a transformative approach by focusing on repairing, replacing, or regenerating human cells, tissues, or organs to restore or establish normal function. This not only leads to enhanced healing of damaged tissues but also restores functionality, offering patients improved quality of life compared to traditional treatments that might only offer symptomatic relief.
2. Reduced Risk of Complications and Rejection:
By utilizing the body’s own regenerative capabilities or biologically compatible materials, regenerative medicine significantly reduces the risk of rejection and complications associated with foreign bodies or transplant rejection. This is particularly beneficial in treatments involving organ transplants or the integration of new tissues.
3. Minimized Need for Surgical Interventions:
Many regenerative medicine approaches, such as stem cell therapy and tissue engineering, are less invasive than conventional surgery. This minimizes the need for surgical interventions, leading to shorter recovery times, reduced pain, and decreased risk of infection.
4. Potential to Cure Previously Untreatable Conditions:
Regenerative medicine holds the promise of curing diseases and conditions that are currently deemed untreatable or chronic. By addressing the root cause of ailments at the cellular or molecular level, it opens new doors to treatments and cures that were once considered beyond reach.
5. Personalized Medicine:
It offers a tailored approach to healing, taking into account an individual’s unique biological setup. This personalization ensures that treatments are more effective and have fewer side effects compared to one-size-fits-all solutions, heralding a new era of personalized medicine.
While evaluating the different suppliers make sure to check the following criteria:
1. Compliance with Regulatory Standards
Ensure the supplier adheres to international and local regulatory standards, including FDA, EMA, and ISO certifications. This is crucial for guaranteeing product safety and efficacy.
2. Quality of Products
Investigate the purity, potency, and consistency of the regenerative medicine products. Suppliers should have robust quality control measures in place.
3. Supply Chain Reliability
Assess the supplier's ability to consistently deliver products on time. A reliable supply chain minimizes the risk of treatment delays.
4. Technical Support and Service
The supplier should offer comprehensive technical support, including product training and after-sales service, ensuring smooth implementation and use of their products.
5. Research and Development Capabilities
Prioritize suppliers that invest in research and development. This indicates a commitment to innovation and the potential for future product improvements.
6. Transparency and Traceability
Choose suppliers that provide transparent documentation on product sourcing, manufacturing processes, and traceability. This is essential for ensuring ethical practices and product quality.
7. Cost-effectiveness
While not compromising on quality, consider the overall cost-effectiveness of the supplier’s products, including any volume discounts or financial terms that can impact budgeting for treatment programs.
Regenerative medicine holds transformative potential across several industries, establishing innovative B2B applications. In the pharmaceutical sector, it underpins a new era of drug development. Companies are leveraging regenerative techniques to create more accurate and human-relevant models for drug testing. This not only accelerates the discovery pipeline but also enhances the predictive value of preclinical trials, minimizing costly failures. The biotechnology industry is another major beneficiary, where regenerative medicine catalyzes the development of advanced therapies. Biotech firms are collaborating to harness stem cells and tissue engineering for creating organoids and synthetic tissues. These advancements are pivotal for personalized medicine, offering unique opportunities for companies specializing in gene therapy and cellular treatments. Healthcare systems are integrating regenerative medicine to innovate patient care strategies. Through partnerships with regenerative medicine enterprises, hospitals and clinics are adopting cell-based therapies and engineered solutions for wound healing, reducing the reliance on traditional surgeries and long-term treatments. This not only improves patient outcomes but also presents cost-saving efficiencies for healthcare providers. Lastly, the veterinary sector is exploring regenerative medicine to extend cutting-edge treatments to animals. Partnerships between veterinary health companies and regenerative medicine firms are emerging, focusing on therapies that accelerate healing in pets and livestock. This crossover offers a novel revenue stream for businesses while advancing veterinary care standards. Collectively, these use cases underscore regenerative medicine's role in driving interdisciplinary advancements, fostering collaborations that stretch beyond traditional industry boundaries.
Regenerative Medicine, a groundbreaking field aimed at restoring the structure and function of damaged tissues and organs, currently spans a wide range of Technology Readiness Levels (TRLs) from basic research (TRL 1-2) through to clinical use (TRL 7-9), depending on the specific technology or application in question. This broad TRL range is due to the multifaceted nature of regenerative medicine, which encompasses stem cell therapy, tissue engineering, and the use of biomaterials and molecules to support the body's own repair mechanisms. Some therapies, such as skin grafts for burn victims and bone marrow transplants, have reached full clinical application (TRL 9), demonstrating proven effectiveness and regulatory approval. In contrast, more cutting-edge applications, like organ regeneration and the engineering of complex tissues, are still in the exploratory or developmental stages (TRL 1-6). These novel approaches face technical challenges, including cell sourcing and differentiation, scaffold design, vascularization of engineered tissues, and immune rejection. The variance in TRLs reflects these hurdles, as well as the interdisciplinary effort required to translate basic biological understanding into practical and reliable medical treatments. The field's progression through the TRLs is further influenced by ethical considerations, regulatory hurdles, and the need for extensive preclinical and clinical testing to ensure safety and efficacy.
In the short-term, regenerative medicine is expected to experience significant advancements in stem cell therapy and tissue engineering. Developments in 3D bioprinting techniques will allow for more precise and customizable tissue constructs, enhancing the treatment of wounds and burns. Additionally, progress in induced pluripotent stem cell (iPSC) technology will improve the efficiency and safety of regenerating damaged tissues, potentially revolutionizing treatments for degenerative diseases. In the mid-term, the focus will shift towards organ regeneration and the refinement of gene editing technologies, such as CRISPR-Cas9. This period will witness the first successful trials of lab-grown organs transplanted into humans, addressing the chronic shortage of organ donors. Concurrently, advancements in gene editing will enable more accurate and less invasive corrections of genetic disorders, paving the way for curing previously untreatable conditions. The integration of artificial intelligence in predictive modeling will also enhance the personalized medicine approach, optimizing regenerative treatment plans for individual patients. Long-term prospects of regenerative medicine herald the era of complete organ regeneration within the body and the mastery of aging reversal techniques. Breakthroughs in bioengineering will likely enable the regeneration of complex organs directly inside patients, significantly reducing the need for external transplants. Moreover, advancements in understanding the molecular mechanisms of aging, coupled with regenerative and gene therapies, could extend human lifespan and quality of life, marking the pinnacle of regenerative medicine's potential to transform healthcare and human biology fundamentally.
